Curet Myriam 4

What Happened Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, exercised 125 option shares on March 2, 2026 (cost $208.90 per share) and then sold a total of 4,853 shares across March 2–3, 2026. The sales were 125 shares on 3/2 at $492.59 ($61,574) and 4,728 shares on 3/3 at $487.18 ($2,303,387), producing roughly $2.365 million in gross proceeds. The filing also reports a derivative disposition of 125 shares at $0.00 on 3/2 (see Key Details).

Key Details

• Transaction dates and prices:
  • 2026-03-02: Exercised 125 options @ $208.90 (acquired) — $26,113 cost.
  • 2026-03-02: Sold 125 shares @ $492.59 — $61,574 proceeds.
  • 2026-03-03: Sold 4,728 shares @ $487.18 — $2,303,387 proceeds.
  • 2026-03-02: Reported derivative disposition of 125 shares @ $0.00.
• Total shares sold: 4,853; total reported gross proceeds: ~$2,364,961.
• Footnotes: Transaction executed under a 10b5-1 trading plan that expires July 29, 2026 (F1). The exercised options are non‑statutory awards granted under the 2010 Incentive Award Plan with standard vesting language (F2).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing timeliness: no late‑filing flag reported in the provided data.

Context

• The March 2 exercise paired with same‑day sales of 125 shares is consistent with a cashless exercise/sale of some exercised shares. The separate larger sale on March 3 occurred under the reported 10b5‑1 plan, which typically means the trades were pre‑planned rather than ad hoc.
• Sales by executives are common and can reflect diversification, tax obligations, or planned liquidity; they do not by themselves indicate company outlook.